BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10396232)

  • 1. Gynaecological effects of tamoxifen.
    Ismail SM
    J Clin Pathol; 1999 Feb; 52(2):83-8. PubMed ID: 10396232
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gynecologic monitoring of tamoxifen treatment of breast cancer].
    Le Bouedec G; Pingeon JM; Fondrinier E; Kauffmann P; Dauplat J
    Rev Fr Gynecol Obstet; 1995; 90(7-9):379-82. PubMed ID: 7481445
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    DeGregorio MW
    J Natl Cancer Inst; 1999 Mar; 91(5):474-5. PubMed ID: 10070949
    [No Abstract]   [Full Text] [Related]  

  • 4. Origin and characteristics of adverse events in aromatase inhibition therapy for breast cancer.
    Dowsett M
    Semin Oncol; 2003 Aug; 30(4 Suppl 14):58-69. PubMed ID: 14513437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen and the uterus and endometrium.
    Cano A; Matallin P; Legua V; Tortajada M; Bonilla-Musoles F
    Lancet; 1989 Feb; 1(8634):376. PubMed ID: 18446930
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to the Letter to the Editor on "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by I. Cohen Ann Oncol 2005; 16: 1399.
    Paridaens R; Morales L; Neven P; Timmerman D
    Ann Oncol; 2005 Aug; 16(8):1402-3; author reply 1402-3. PubMed ID: 15870087
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
    Kuzmanov B
    Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynaecological aspects of tamoxifen treatment in breast cancer patients.
    Obwegeser R; Auerbach L; Kubista E
    Cancer Treat Rev; 1997; 23(5-6):289-304. PubMed ID: 9465881
    [No Abstract]   [Full Text] [Related]  

  • 10. Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology.
    Morales L; Paridaens R; Timmerman D; Neven P
    Clin Cancer Res; 2006 Sep; 12(18):5603. PubMed ID: 17000698
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen and the endometrium.
    Barakat RR
    Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of tamoxifen treatment on the endometrium.
    Daniel Y; Inbar M; Bar-Am A; Peyser MR; Lessing JB
    Fertil Steril; 1996 Jun; 65(6):1083-9. PubMed ID: 8641477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign gynecologic conditions in Tamoxifen-treated patients.
    Cohen I
    Am J Obstet Gynecol; 2006 Apr; 194(4):1204-5; author reply 1205. PubMed ID: 16580343
    [No Abstract]   [Full Text] [Related]  

  • 14. Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.
    Neri F; Maggino T
    Eur J Gynaecol Oncol; 2009; 30(4):357-60. PubMed ID: 19761121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen retinopathy.
    Lee AG
    J Neuroophthalmol; 1998 Dec; 18(4):276. PubMed ID: 9858011
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen and the uterus: an old drug tested by new modalities.
    Achiron R; Grisaru D; Golan-Porat N; Lipitz S
    Ultrasound Obstet Gynecol; 1996 May; 7(5):374-8. PubMed ID: 8774108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen induced endometrial abnormalities: evaluation by saline infusion sonohysterography.
    Jaeger BM; Grumbach K
    Md Med J; 1997 Sep; 46(8):433-5. PubMed ID: 9294952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging.
    Kraft JK; Hughes T
    Clin Radiol; 2006 Feb; 61(2):198-201. PubMed ID: 16439226
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expansive uterine myoma during tamoxifen therapy. 11 cases].
    Le Bouëdec G; de Latour M; Dauplat J
    Presse Med; 1995 Nov; 24(36):1694-6. PubMed ID: 8545398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-induced total alopecia.
    Puglisi F; Aprile G; Sobrero A
    Ann Intern Med; 2001 Jun; 134(12):1154-5. PubMed ID: 11412069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.